Prothena Corp. plc diskutieren
Prothena Corp. plc
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
9,11 €
3,00 %
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target raised by analysts at Piper Sandler from $94.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $48.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $30.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Chardan Capital from $40.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Piper Sandler from $110.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Ratings data for PRTA provided by MarketBeat
Prothena Corporation plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Corporation plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $18.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $18.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (PRTA) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for PRTA provided by MarketBeat
Neueste Beiträge
Benchmark_Co_ in Trade Desk Inc diskutieren